Correlation Between Hormel Foods and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hormel Foods and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hormel Foods and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hormel Foods and Integrated Biopharma, you can compare the effects of market volatilities on Hormel Foods and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hormel Foods with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hormel Foods and Integrated Biopharma.

Diversification Opportunities for Hormel Foods and Integrated Biopharma

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Hormel and Integrated is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Hormel Foods and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Hormel Foods is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hormel Foods are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Hormel Foods i.e., Hormel Foods and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Hormel Foods and Integrated Biopharma

Considering the 90-day investment horizon Hormel Foods is expected to under-perform the Integrated Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Hormel Foods is 2.94 times less risky than Integrated Biopharma. The stock trades about -0.04 of its potential returns per unit of risk. The Integrated Biopharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  39.00  in Integrated Biopharma on November 2, 2024 and sell it today you would lose (6.00) from holding Integrated Biopharma or give up 15.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy22.52%
ValuesDaily Returns

Hormel Foods  vs.  Integrated Biopharma

 Performance 
       Timeline  
Hormel Foods 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hormel Foods has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Hormel Foods is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Hormel Foods and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hormel Foods and Integrated Biopharma

The main advantage of trading using opposite Hormel Foods and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hormel Foods position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind Hormel Foods and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital